Daniel H. Fowler, M.D.
Experimental Transplantation and Immunology Branch
Head, Cytokine Biology Section
National Cancer Institute
10 Center Drive
CRC/Room 3-3330
Bethesda, MD 20892
Phone: 301-435-8641
Fax: 301-480-4354
dhfowler@helix.nih.gov
Dr. Fowler is a tenure-track clinical investigator at the Center for Cancer Research, National Cancer Institute (NCI) in Bethesda, Md. Dr. Fowler received his M.D. (1987) from Wayne State University in Detroit, Mich. After internal medicine and pediatrics training at Wayne State, Dr. Fowler completed the medical oncology fellowship at NCI (1993). After fellowship, Dr. Fowler evaluated the role of Th1/Th2 and Tc1/Tc2 donor T-cell subsets in the modulation of murine allogeneic transplantation responses, and is currently implementing pilot clinical trials to evaluate Th2 and Tc2 cell allograft engineering strategies.
Dr. Fowler's Clinical Trials:
NCI is currently conducting the following trials for patients with hematological malignancies or kidney cancer. Click on the trials below for additional details, including a summary of eligibility criteria, treatment plan, and information on how to contact the study team directly.
Back to Top
